PATENT CLAIM ANALYSIS

Application Number: 16287870
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-10
Patent Classification: ["514", "274000"]

Abstract:
The present invention relates to 4-methyldihydropyrimidinone compounds, or pharmaceutically acceptable salts thereof, having RORγ antagonist activity, pharmaceutical compositions comprising the same, and pharmaceutical use thereof. A compound of Formula (1) or (2) or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the same, and pharmaceutical use thereof are provided.

Claim (Index 4):
A pharmaceutical composition comprising a compound according to  claim 2  or  3  or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 99.0
- Lexical Diversity: 1.63158
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14426630', '15514584', '13753926', '15370292', '15370618']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7724116850337834
- 35 USC 102 Novelty (BERT): 0.4921822356976472
- Combined Prediction Score: 0.7443887401001698
- Mean Citation Score: 255.638938
- Max Citation Score: 260.8459
- Similarity Product: 218.48676280772685

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test